Craig Hallum initiated coverage on shares of Vireo Health International (OTCMKTS:VREOF) in a note issued to investors on Wednesday, The Fly reports. The brokerage set a “buy” rating on the stock.

Separately, Canaccord Genuity restated a “buy” rating and set a $2.00 price objective on shares of Vireo Health International in a report on Thursday, August 27th.

Shares of OTCMKTS VREOF traded down $0.01 during midday trading on Wednesday, hitting $0.77. 60,578 shares of the company traded hands, compared to its average volume of 159,966. Vireo Health International has a 12-month low of $0.20 and a 12-month high of $1.97. The firm has a 50-day moving average of $0.66.

About Vireo Health International

Vireo Health International Inc operates in cannabis industry in the United States. It engages in the cultivation, production, and sale of medical cannabis products to company owned and third party dispensaries. The company sells and distributes a suite of products through dispensaries, home delivery, and wholesale channels.

Featured Story: What are different types of coverage ratios?

The Fly

Receive News & Ratings for Vireo Health International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vireo Health International and related companies with's FREE daily email newsletter.